SOBI and IPHA Related Headlines

Go Back

Aug 10, 2026 02:33AM Sobi licenses lacutamab from Innate Pharma in $75M upfront deal

Aug 10, 2026 02:32AM Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

SOBI and IPHA Related Press Releases

Go Back

Aug 10, 2026 02:32AM Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

SOBI and IPHA Related SEC Filings

Go Back